This 2022 systematic review and network meta-analysis evaluated 13 randomized controlled trials involving 944 patients to assess the efficacy of a low FODMAP diet in managing irritable bowel syndrome (IBS). The analysis revealed that the low FODMAP diet ranked highest in improving global IBS symptoms, abdominal pain, bloating, and bowel
